Pressemitteilung BoxID: 209233 (Greiner Bio-One GmbH)
  • Greiner Bio-One GmbH
  • Maybachstraße 2
  • 72636 Frickenhausen
  • Ansprechpartner
  • Kerstin Mahle
  • +49 (7022) 948-486

Innovative surface leading to considerably higher cell yields

For the first time at Biotechnica 2008, Greiner Bio-One presented Advanced TC(tm) cell culture products with an innovative polymer modification.

(PresseBox) (Frickenhausen, ) For the first time at Biotechnica 2008, Greiner Bio-One presented Advanced TC(tm) cell culture products with an innovative polymer modification. The special surface of the new product range optimises cultivation of fastidious cells and facilitates complex experimental approaches.

To successfully cultivate primary cells or particularly sensitive immortalised cell lines in vitro, it is necessary to mimic the specific in vivo conditions of these cells as accurate as possible. The new Advanced TC(tm) surface has been designed in such a way to positively influence cellular function and properties.
This enables researchers to cultivate a wide range of sensitive cells as well as cells under restrictive growth conditions using serum-reduced or serum-free media, for example. Distinct primary adherence is achieved after just four hours.
Cell cultures on the Advanced TC(tm) surface exhibit higher proliferation rates than on other commonly used cell culture products. In addition, less cell material is lost as a result of the improved adherence on the surface during automated washing and pipetting steps. The cell yield is significantly increased compared to conventional cell culture products and test results are more consistent.
The cell-typical morphology is retained even if the cells are subject to transfection or transduction processes. It has even been possible to observe increased transgene activity in transfected cells. Due to their special properties, Advanced TC(tm) cell culture vessels are comparable in a variety of applications with the effectiveness of a biological surface.

Greiner Bio-One GmbH

Greiner Bio-One GmbH - BioScience Division

Greiner Bio-One is specialised in the development, production and distribution of plastic laboratory equipment. The company is technology partner for universities, research institutes and the diagnostic, pharmaceutical and biotechnology industries as well. With the BioScience division, Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures, as well as microplates for high-throughput screening, allowing industry and research most rapid and efficient drug screening. Additionally Greiner Bio-One develops innovative biochip technologies for genotyping.
Under the management of Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen (Baden-Württemberg) controls the whole research and development activities in the product ranges Cell Culture, High-Throughput Screening, Biochips and OEM.
Greiner Bio-One GmbH is a division of Greiner Bio-One International AG, based in Kremsmuenster (Austria). Today Greiner Bio-One International AG generates a turnover of 241.7 million Euro. It has over 1,200 employees and operates globally with 18 own subsidiaries and numerous distributors in more than 100 countries.

Further information about Greiner Bio-One can be obtained from:

Greiner Bio-One GmbH
Simone Hoffmann und Kerstin Mahle
Maybachstraße 2
72636 Frickenhausen
Telefon: +49 (0) 70 22) 948 - 0
Fax: +49 (0) 70 22) 948 - 514

Zeeb Kommunikation
Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
Telefon: +49 (0)7 11 6070719
Fax: +49 (0)7 11 6070739
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an